Annual Cash & Cash Equivalents
$488.30 M
-$157.20 M-24.35%
31 December 2023
Summary:
Bruker annual cash & cash equivalents is currently $488.30 million, with the most recent change of -$157.20 million (-24.35%) on 31 December 2023. During the last 3 years, it has fallen by -$193.50 million (-28.38%). BRKR annual cash & cash equivalents is now -54.29% below its all-time high of $1.07 billion, reached on 31 December 2021.BRKR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$148.10 M
-$21.60 M-12.73%
30 September 2024
Summary:
Bruker quarterly cash and cash equivalents is currently $148.10 million, with the most recent change of -$21.60 million (-12.73%) on 30 September 2024. Over the past year, it has dropped by -$215.50 million (-59.27%). BRKR quarterly cash and cash equivalents is now -86.14% below its all-time high of $1.07 billion, reached on 31 December 2021.BRKR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BRKR Cash And Cash Equivalents Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -24.4% | -59.3% |
3 y3 years | -28.4% | -74.2% |
5 y5 years | +51.5% | -50.0% |
BRKR Cash And Cash Equivalents High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -54.3% | at low | -86.1% | at low |
5 y | 5 years | -54.3% | +51.5% | -86.1% | at low |
alltime | all time | -54.3% | >+9999.0% | -86.1% | +6418.5% |
Bruker Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $148.10 M(-12.7%) |
June 2024 | - | $169.70 M(-50.1%) |
Mar 2024 | - | $340.10 M(-30.4%) |
Dec 2023 | $488.30 M(-24.4%) | $488.30 M(+34.3%) |
Sept 2023 | - | $363.60 M(-36.7%) |
June 2023 | - | $574.80 M(-3.9%) |
Mar 2023 | - | $597.90 M(-7.4%) |
Dec 2022 | $645.50 M(-39.6%) | $645.50 M(+3.1%) |
Sept 2022 | - | $626.20 M(-13.4%) |
June 2022 | - | $723.00 M(-11.4%) |
Mar 2022 | - | $816.10 M(-23.6%) |
Dec 2021 | $1.07 B(+56.7%) | $1.07 B(+86.4%) |
Sept 2021 | - | $573.00 M(-5.8%) |
June 2021 | - | $608.10 M(-12.7%) |
Mar 2021 | - | $696.80 M(+2.2%) |
Dec 2020 | $681.80 M(+0.5%) | $681.80 M(+20.2%) |
Sept 2020 | - | $567.10 M(-24.1%) |
June 2020 | - | $746.80 M(-6.1%) |
Mar 2020 | - | $795.50 M(+17.3%) |
Dec 2019 | $678.30 M(+110.4%) | $678.30 M(+128.9%) |
Sept 2019 | - | $296.30 M(+4.9%) |
June 2019 | - | $282.50 M(-5.5%) |
Mar 2019 | - | $298.80 M(-7.3%) |
Dec 2018 | $322.40 M(-0.8%) | $322.40 M(+19.4%) |
Sept 2018 | - | $270.10 M(+4.4%) |
June 2018 | - | $258.70 M(-8.9%) |
Mar 2018 | - | $283.90 M(-12.6%) |
Dec 2017 | $325.00 M(-5.1%) | $325.00 M(+23.2%) |
Sept 2017 | - | $263.90 M(+21.2%) |
June 2017 | - | $217.70 M(-21.5%) |
Mar 2017 | - | $277.50 M(-19.0%) |
Dec 2016 | $342.40 M(+28.2%) | $342.40 M(+22.9%) |
Sept 2016 | - | $278.70 M(+19.9%) |
June 2016 | - | $232.50 M(+10.8%) |
Mar 2016 | - | $209.90 M(-21.4%) |
Dec 2015 | $267.10 M(-16.4%) | $267.10 M(-19.3%) |
Sept 2015 | - | $331.00 M(+3.2%) |
June 2015 | - | $320.80 M(-4.1%) |
Mar 2015 | - | $334.50 M(+4.7%) |
Dec 2014 | $319.50 M(-27.2%) | $319.50 M(-2.9%) |
Sept 2014 | - | $329.20 M(-15.5%) |
June 2014 | - | $389.80 M(-14.1%) |
Mar 2014 | - | $454.00 M(+3.5%) |
Dec 2013 | $438.70 M(+41.2%) | $438.70 M(+43.0%) |
Sept 2013 | - | $306.80 M(+22.3%) |
June 2013 | - | $250.90 M(-6.9%) |
Mar 2013 | - | $269.40 M(-13.3%) |
Dec 2012 | $310.60 M | $310.60 M(+28.3%) |
Sept 2012 | - | $242.10 M(+0.7%) |
June 2012 | - | $240.30 M(+4.7%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2012 | - | $229.50 M(-6.7%) |
Dec 2011 | $246.00 M(+6.8%) | $246.00 M(+25.6%) |
Sept 2011 | - | $195.80 M(+15.3%) |
June 2011 | - | $169.80 M(-12.2%) |
Mar 2011 | - | $193.30 M(-16.1%) |
Dec 2010 | $230.40 M(+11.3%) | $230.40 M(+22.6%) |
Sept 2010 | - | $188.00 M(+0.2%) |
June 2010 | - | $187.60 M(-7.6%) |
Mar 2010 | - | $203.10 M(-1.9%) |
Dec 2009 | $207.10 M(+24.6%) | $207.10 M(+39.5%) |
Sept 2009 | - | $148.50 M(-2.7%) |
June 2009 | - | $152.60 M(+2.8%) |
Mar 2009 | - | $148.40 M(-10.7%) |
Dec 2008 | $166.20 M(-50.0%) | $166.20 M(+97.0%) |
Sept 2008 | - | $84.38 M(-32.7%) |
June 2008 | - | $125.40 M(-58.0%) |
Mar 2008 | - | $298.26 M(-10.3%) |
Dec 2007 | $332.40 M(+537.4%) | $332.40 M(+754.4%) |
Sept 2007 | - | $38.90 M(-7.2%) |
June 2007 | - | $41.93 M(-24.7%) |
Mar 2007 | - | $55.69 M(+6.8%) |
Dec 2006 | $52.15 M(-16.7%) | $52.15 M(+18.1%) |
Sept 2006 | - | $44.15 M(-54.3%) |
June 2006 | - | $96.60 M(+44.8%) |
Mar 2006 | - | $66.70 M(+6.5%) |
Dec 2005 | $62.63 M(-19.4%) | $62.63 M(-34.3%) |
Sept 2005 | - | $95.34 M(+3.6%) |
June 2005 | - | $92.04 M(+8.5%) |
Mar 2005 | - | $84.82 M(+9.2%) |
Dec 2004 | $77.69 M(+1.1%) | $77.69 M(+1.4%) |
Sept 2004 | - | $76.62 M(-3.3%) |
June 2004 | - | $79.22 M(+3.3%) |
Mar 2004 | - | $76.67 M(-0.2%) |
Dec 2003 | $76.84 M(-9.4%) | $76.84 M(+20.3%) |
Sept 2003 | - | $63.87 M(+36.4%) |
June 2003 | - | $46.81 M(-4.4%) |
Mar 2003 | - | $48.97 M(-42.3%) |
Dec 2002 | $84.81 M(+911.9%) | $84.81 M(+700.0%) |
Sept 2002 | - | $10.60 M(+59.7%) |
June 2002 | - | $6.64 M(-1.6%) |
Mar 2002 | - | $6.74 M(-19.5%) |
Dec 2001 | $8.38 M(-61.4%) | $8.38 M(+1.4%) |
Sept 2001 | - | $8.26 M(-35.7%) |
June 2001 | - | $12.84 M(+5.8%) |
Mar 2001 | - | $12.14 M(-44.1%) |
Dec 2000 | $21.73 M(+789.6%) | $21.73 M(-79.2%) |
Sept 2000 | - | $104.46 M(+4497.9%) |
June 2000 | - | $2.27 M(-41.8%) |
Mar 2000 | - | $3.90 M |
Dec 1999 | $2.44 M | - |
FAQ
- What is Bruker annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bruker?
- What is Bruker annual cash & cash equivalents year-on-year change?
- What is Bruker quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Bruker?
- What is Bruker quarterly cash and cash equivalents year-on-year change?
What is Bruker annual cash & cash equivalents?
The current annual cash & cash equivalents of BRKR is $488.30 M
What is the all time high annual cash & cash equivalents for Bruker?
Bruker all-time high annual cash & cash equivalents is $1.07 B
What is Bruker annual cash & cash equivalents year-on-year change?
Over the past year, BRKR annual cash & cash equivalents has changed by -$157.20 M (-24.35%)
What is Bruker quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BRKR is $148.10 M
What is the all time high quarterly cash and cash equivalents for Bruker?
Bruker all-time high quarterly cash and cash equivalents is $1.07 B
What is Bruker quarterly cash and cash equivalents year-on-year change?
Over the past year, BRKR quarterly cash and cash equivalents has changed by -$215.50 M (-59.27%)